IDPC and civil society partners highlight the deep-rooted racial inequalities in drug law enforcement, urging for reforms to dismantle systemic harm and discrimination.
A new McGill University study finds that Toronto’s supervised drug consumption sites were not linked to rising crime — and in most cases, crime declined over time.
Recent health data reveal that Ghana's Narcotics Control Commission Act (2020) has worsened HIV outcomes by failing to bring about a public health approach to drugs.
Evaluation of Switzerland’s cannabis pilot trials finds high participant satisfaction, no notable public-order incidents, and early signs that legal access models can reduce reliance on the illicit market.
Harm Reduction International discusses a 'global paradox' in which growing policy recognition and community resilience collide with devastating funding cuts that now threaten decades of harm reduction progress.
UNDP provides guidance to ensure that digital technologies for HIV and health are used ethically, protect human rights, and advance equity in the digital age.
Bewley-Taylor et al. find the GDPI useful for comparing international drug policy, and suggest improvements to better handle uncertainty and diverse data.
The 2025 EU Drug Report uncovers a rapidly evolving drug landscape, fuelled by synthetic substances, tech innovation, and global instability. With rising health and security threats, the report places urgent emphasis on real-time data, early warning systems, and bold cross-sector collaboration.
Wire et al. conclude that Oregon's drug decriminalisation did not lead to an increase in emergency service calls and encourage strategies to counter public misconceptions of future reforms.
